Beyond Markets

As Singapore has embarked on the first stage of a four-step reopening with the end goal being a Covid-resilient nation and a “new normal” for the island state, we are publishing a special mini-series on Singapore’s future after the pandemic. With currently more than 8.5 million vaccination shots administered and 73% of its population fully vaccinated, Singapore is the 3rd most vaccinated nation behind Malta and UAE. Also, the number of Covid cases has dropped significantly from over 200 in the last few months to less than 50. The government has therefore outlined a controlled four-step reopening plan, which entails easing travel restrictions, changes in healthcare protocols, increased size limits for events among other and greater rostered routine testing to facilitate further economic reopening. As a nation, Singapore will also move to treating the virus as endemic rather than pandemic, meaning learning to live with the virus, and entering a new normal. This mini-series explores the implications from different perspectives as Singapore embarks on this journey.

In Episode 1 of our mini-series Jen-Ai Chua, Research Equity Analyst Asia, and Pearlyn Wong, Head of Investment Promotion & Solutions Asia discuss the various implications of Singapore’s reopening approach. They analyse what it means for Singapore’s economy and which sectors stand to benefit the most from the re-opening measures, and explore potential pitfalls that investors should be aware of. In their economic outlook they also share how investors should position themselves for the next six to twelve months. Finally, our experts explain why the pandemic has brought ESG issues to the top of the policy agenda for many countries including Singapore. To find out more, listen to this special episode now.

What is Beyond Markets?

“Beyond Markets” by Julius Baer is a series featuring conversations with experts to share recent market developments, key insights, and strategic inputs from around the globe. In each episode, we cut through the noise to offer practical advice and macro research on today’s shifting economic and market landscape.
The information contained in this podcast is marketing material. Opinions expressed do not constitute independent financial/investment research, investment advice, or an offer to buy or sell securities by Julius Baer. Please refer to www.juliusbaer.com/legal/podcasts for important legal information prior to listening to this podcast.